Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 2/20 | 0.40 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CFTR | P13569 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MMP13 | P45452 | 1/20 | 0.34 |
| ▸ | MMP14 | P50281 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.33 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.33 |
| ▸ | CACNA1I | Q9P0X4 | 2/20 | 0.33 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19767100 | 0.86 | ACACB (0.37) | SMN1; SMN2BACE1BACE2ACACBSCN9A | |
| SCHEMBL17992230 | 0.85 | BACE1 (0.38) | SMN1; SMN2BACE1BACE2SCN9AMMP13 | |
| SCHEMBL19672945 | 0.81 | HTT (0.41) | KMT2AHTTSMN1; SMN2BACE1BACE2 | |
| SCHEMBL29120290 | 0.80 | MEN1 (0.33) | KMT2AMEN1ALDH1A1TSHRP4HTM | |
| SCHEMBL1974946 | 0.79 | P4HTM (0.52) | KMT2AHTTSMN1; SMN2BACE1BACE2 | |
| SCHEMBL15669996 | 0.79 | KMT2A (0.44) | KMT2AHTTSMN1; SMN2BACE1BACE2 | |
| SCHEMBL1973974 | 0.79 | KMT2A (0.48) | KMT2AHTTSMN1; SMN2BACE1BACE2 | |
| SCHEMBL17668770 | 0.78 | KMT2A (0.47) | KMT2AHTTSMN1; SMN2BACE1BACE2 | |
| SCHEMBL17992215 | 0.77 | BACE1 (0.39) | KMT2AHTTSMN1; SMN2BACE1BACE2 | |
| SCHEMBL20601596 | 0.75 | ACACB (0.34) | ACACBP4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10173997-B2 | Bipyridine compound and use of same for noxious arthropod control | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-01-08 | — | — | US | disclosed |
| US-20180009778-A1 | BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-01-11 | — | — | US | disclosed |
| WO-2017073733-A1 | PEST CONTROL COMPOSITION AND USE THEREOF | 住友化学株式会社 | 2017-05-04 | — | — | WO | disclosed |
| WO-2016121969-A1 | BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | 住友化学株式会社 | 2016-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009778-A1 | BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | BBOX1, ACHE, MORF4L1 | KMT2A 4252/4885HTT 4092/4885SMN1; SMN2 1146/4885 |
| US-10173997-B2 | Bipyridine compound and use of same for noxious arthropod control | BBOX1, ACHE, MORF4L1 | KMT2A 4252/4885HTT 4092/4885SMN1; SMN2 1146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.